Review on uremic toxins: classification, concentration, and interindividual variability
- PMID: 12675874
- DOI: 10.1046/j.1523-1755.2003.00924.x
Review on uremic toxins: classification, concentration, and interindividual variability
Erratum in
-
Corrigendum to "Vanholder R, De Smet R, Glorieux G, et al. Review on uremic toxins: classification, concentration, and interindividual variability." Kidney Int. 2003;63:1934-1943.Kidney Int. 2020 Nov;98(5):1354. doi: 10.1016/j.kint.2020.10.001. Kidney Int. 2020. PMID: 33126986 No abstract available.
Abstract
Background: The choice of the correct concentration of potential uremic toxins for in vitro, ex vivo, and in vivo experiments remains a major area of concern; errors at this level might result in incorrect decisions regarding therpeutic correction of uremia and related clinical complications.
Methods: An encyclopedic list of uremic retention solutes was composed, containing their mean normal concentration (CN), their highest mean/median uremic concentration (CU), their highest concentration ever reported in uremia (CMAX), and their molecular weight. A literature search of 857 publications on uremic toxicity resulted in the selection of data reported in 55 publications on 90 compounds, published between 1968 and 2002.
Results: For all compounds, CU and/or CMAX exceeded CN. Molecular weight was lower than 500 D for 68 compounds; of the remaining 22 middle molecules, 12 exceeded 12,000 D. CU ranged from 32.0 ng/L (methionine-enkephalin) up to 2.3 g/L (urea). CU in the ng/L range was found especially for the middle molecules (10/22; 45.5%), compared with 2/68 (2.9%) for a molecular weight <500 D (P < 0.002). Twenty-five solutes (27.8%) were protein bound. Most of them had a molecular weight <500 D except for leptin and retinol-binding protein. The ratio CU/CN, an index of the concentration range over which toxicity is exerted, exceeded 15 in the case of 20 compounds. The highest values were registered for several guanidines, protein-bound compounds, and middle molecules, to a large extent compounds with known toxicity. A ratio of CMAX/CU <4, pointing to a Gaussian distribution, was found for the majority of the compounds (74/90; 82%). For some compounds, however, this ratio largely exceeded 4 [e.g., for leptin (6.81) or indole-3-acetic acid (10.37)], pointing to other influencing factors than renal function, such as gender, genetic predisposition, proteolytic breakdown, posttranslation modification, general condition, or nutritional status.
Conclusion: Concentrations of retention solutes in uremia vary over a broad range, from nanograms per liter to grams per liter. Low concentrations are found especially for the middle molecules. A substantial number of molecules are protein bound and/or middle molecules, and many of these exert toxicity and are characterized by a high range of toxic over normal concentration (CU/CN ratio). Hence, uremic retention is a complex problem that concerns many more solutes than the current markers of urea and creatinine alone. This list provides a basis for systematic analytic approaches to map the relative importance of the enlisted families of toxins.
Similar articles
-
Biochemical and clinical evidence for uremic toxicity.Artif Organs. 2004 Mar;28(3):248-53. doi: 10.1111/j.1525-1594.2004.47315.x. Artif Organs. 2004. PMID: 15046622 Review.
-
[Uremic toxins: the case of protein-bound compounds].G Ital Nefrol. 2010 Sep-Oct;27(5):498-507. G Ital Nefrol. 2010. PMID: 20922681 Italian.
-
[Uremic toxins].Nephrologie. 2003;24(7):373-6. Nephrologie. 2003. PMID: 14650749 Review. French.
-
Low water-soluble uremic toxins.Adv Ren Replace Ther. 2003 Oct;10(4):257-69. doi: 10.1053/j.arrt.2003.08.003. Adv Ren Replace Ther. 2003. PMID: 14681857 Review.
-
Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update.Toxins (Basel). 2018 Jan 8;10(1):33. doi: 10.3390/toxins10010033. Toxins (Basel). 2018. PMID: 29316724 Free PMC article. Review.
Cited by
-
The effect of lipoic acid on cyanate toxicity in different structures of the rat brain.Neurotox Res. 2013 Oct;24(3):345-57. doi: 10.1007/s12640-013-9395-2. Epub 2013 Apr 27. Neurotox Res. 2013. PMID: 23625581 Free PMC article.
-
Effect of uremic toxins on hippocampal cell damage: analysis in vitro and in rat model of chronic kidney disease.Heliyon. 2021 Feb 10;7(2):e06221. doi: 10.1016/j.heliyon.2021.e06221. eCollection 2021 Feb. Heliyon. 2021. PMID: 33659745 Free PMC article.
-
Effect of frequent or extended hemodialysis on cardiovascular parameters: a meta-analysis.Am J Kidney Dis. 2012 May;59(5):689-99. doi: 10.1053/j.ajkd.2011.12.020. Epub 2012 Feb 25. Am J Kidney Dis. 2012. PMID: 22370022 Free PMC article.
-
Uremic Toxins: An Alarming Danger Concerning the Cardiovascular System.Front Physiol. 2021 May 14;12:686249. doi: 10.3389/fphys.2021.686249. eCollection 2021. Front Physiol. 2021. PMID: 34054588 Free PMC article. Review.
-
Serum Anion Gap Predicts All-Cause Mortality in Patients with Advanced Chronic Kidney Disease: A Retrospective Analysis of a Randomized Controlled Study.PLoS One. 2016 Jun 1;11(6):e0156381. doi: 10.1371/journal.pone.0156381. eCollection 2016. PLoS One. 2016. PMID: 27249416 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous